Biomaterial-associated Pseudomonas aeruginosa biofilm infections constitute cascade of host immune reactions ultimately leading towards implant failure. Due to lack of relevant in vivo biofilm models, majority of the studies report host immune responses against free living or planktonic bacteria while bacteria in clinical situations live more frequently as biofilm communities than as single cells. Present study investigated host immune responses against biomaterial-associated P. aeruginosa biofilms in a clinically relevant mouse model. Previously, we reported metallic magnesium, a prospective biodegradable implant, to be permissive for bacterial biofilms in vivo even though it exhibits antibacterial properties in vitro. Therefore, magnesium was employed as biomaterial to investigate in vivo biofilm formation and associated host immune responses by using two P. aeruginosa strains and two mouse strains. P. aeruginosa 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 3 could not eliminate the local infection for up to two weeks, there was no apparent systemic bacteremia and all animals investigated survived the infection.
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Introduction
Applications of medical implants have increased manifold in humans for reasons such as the organs loss due to chronic diseases and accidents [1] . Pseudomonas aeruginosa is an principal pathogen responsible for biofilm formation on medical implants [2, 3] .
Biofilms are the most precarious infections since they are thousands of times more resistant against conventional antibiotics and host immune systems [4] [5] [6] . Biomaterialassociated biofilm infections are mostly treated by surgical removal of implant from infected tissue followed by administration of antibiotics [7] . Such inevitable surgery together with antibiotic administration incurs huge losses on patient health and economy. Moreover, biofilm infections trigger unrestrained host immune reactions which can cause immunosuppression, shock, transudation in organs and defects in coagulation [8] [9] [10] . Innate and adaptive immune responses to various pathogens comprise of accumulating phagocytic cells and inflammatory cytokines, among others interferons (IFNs), play a critical role [11, 12] . However, performance of host immune responses is compromised when most of the implant materials require a surgical procedure for their insertion into body [13, 14] . Initially, open wounds, body liquidfilled gaps between the implant and the surrounding tissue, structural, mechanical and chemical properties of implants hinder immune cells from invading bacteria [15] [16] [17] [18] [19] .
Later, bacteria secrete extracellular matrix material (ECM) which prevents phagocytic immune cells such as macrophages and neutrophilic granulocytes from engulfing bacteria. The ECM also limits the diffusion rate of nutrients and metabolites, thereby reducing the bacterial metabolic activities. This impedes the efficacy of proliferationdependent antibiotics thereby reducing efficacy of various antibiotics [20] [21] [22] . To counter biofilm infections and to augment the performance of implant materials, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 A c c e p t e d M a n u s c r i p t 5 various strategies have been introduced. These include, metal alloy implants with antimicrobial properties, antibacterial as well as anti-adhesive nanoparticles coatings and localized antimicrobial drug delivery systems on implant surfaces [23, 24] . Metallic magnesium as biodegradable implant material is being highly investigated for clinical applications due to its in vitro bactericidal corrosion products and antibacterial properties which can efficiently counter biomaterial-associated biofilm infections [25] [26] [27] [28] . Magnesium alloys are presently under intense investigation as degradable, yet sturdy implant materials that could potentially be used for temporary applications to improve bone-healing and avoid long-term side effects associated with permanent metallic implants [29] [30] [31] . From our previous investigation as well as from literature, magnesium and its alloys are reported susceptible to P. aeruginosa colonization and subsequent biofilm formation [32] [33] [34] . Since, limited information exists on the capacity of biomaterial-associated P. aeruginosa biofilms to escape the local innate immune defense and spread into adjacent tissue or even systemically due to lack of clinically relevant biofilm mouse models [35, 36] . In addition, there is no in vivo information about the role of interferons against biofilm infections. Therefore, we employed in vivo P. aeruginosa biofilm formation on magnesium as a mouse model and report here P. aeruginosa biofilm repercussions directly on the implant interface, in the adjacent tissue and systemically. We used noninvasive in vivo imaging system to monitor in vivo biofilm formation and interferon response against these infections [37] . Side by side, morphological, histological and electron microscopic analyses were performed to determine biofilm effects on host. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
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Material and Methods
Preparation of magnesium samples and bacterial cultures
6
Disc shaped magnesium samples with (99.95% purity) having 5 mm diameter and 2 mm thickness were prepared and processed as described previously [38] .
Bioluminescent and wild type P. aeruginosa strains were streaked on LB agar plates and incubated for 18h at 37 °C [39, 40] . For liquid cultures, isolates were cultured in BL broth medium and kept at 37 °C with shaking speed of 150 RPM till the desired OD600=0.1 was achieved. The bacterial suspension was then immediately placed on crushed wet ice to inhibit further growth.
Surgical procedures and in vivo infections
8 weeks old healthy female wild-type BALB/c mice were purchased (Harlan Winkelmann, Borchen, Germany) and IFN-β-reporter mice (IFN-β +/Δβ-luc ) on the BALB/c background (ifnb1 tm1.2Lien ) [41] were bred at the Helmholtz Centre for Infection
Research, Braunschweig. Mice were kept in individually ventilated cages in a dedicated infection facility with water and food ad libitum. Before surgery, animals were anesthetized with xylazine (4mg/Kg) and ketamine (10mg/Kg) and fur was removed at the site of surgery using a hair trimmer (Aesculap Suhl GmbH, Germany). Under sterile conditions in a laminar flow hood, 0.5 cm long incisions in the skin were made at three sites on the back of the mice using surgical scissors (Fine Science Tools GmbH, Heidelberg, Germany). A subcutaneous pouch was created from the incisions and 99.95 % pure magnesium discs with 5 mm diameter and 2 mm thickness were inserted [26] . implanted discs [42, 43] . For monitoring the host interferon response, wild type P. A c c e p t e d M a n u s c r i p t 7 aeruginosa (PAO1) were injected on subcutaneously implanted magnesium discs in IFN-β reporter (IFN-β +/Δβ-luc ) BALB/c mice, which allow tracking of IFN-β gene induction [41] . D-luciferin (150 mg/Kg) (Calipers) in PBS was injected intraperitoneally 15 min. before examination by in vivo imaging. In vivo luminescence was recorded by using a Xenogen IVIS-200 optical imaging system (Caliper Life Sciences) equipped with XGI-8 gas anesthesia unit (Caliper Life Sciences, Hopkinton, MA) using 2% isoflurane. IFN-β-reporter mice were examined daily for a period of two weeks. BALB/c mice were euthanized on 8 th day post-infection and then magnesium implants with adjacent tissue were removed and fixed in a buffered formalin solution according to standard procedures [32] . Animal experiments were performed with the permission of the Lower Saxony State Office for Consumer Protection and Food Safety (LAVES; Oldenburg, Germany) under approval number 33.42502/07-10.5.
Field emission scanning electron microscopy
For electron microscopic examination, explanted magnesium and tissue samples were sputter coated with palladium-gold. Peri-implant tissues were fixed with 5% formaldehyde and 2% glutaraldehyde in HEPES buffer (100 mM HEPES, 90 mM sucrose, 10 mM MgCl2, 10 mM CaCl2, pH 6.9) washed twice in TE buffer (10 mM TRIS, 2 mM MEDTA, pH 6.9), dehydrated in a graded series of acetone (10, 30, 50, 70, 90, 100%) solutions for 15 min on ice and then dehydrated further in 100% acetone at room temperature. Subsequently, critical-point drying was performed with liquid CO2 (CPD300, Leica or CPD030 Bal-Tec). Dry tissue samples were sputter coated with palladium-gold (SCD500, Bal-Tec). Samples were examined using a Zeiss Merlin field emission scanning electron microscope at an acceleration of 5 kV and by using the Zeiss SmartSEM software version 5.05 (Zeiss, Oberkochen, Germany). A c c e p t e d M a n u s c r i p t 8
Transmission electron microscopy
Mice bearing infected implants were euthanized with CO2 followed by cervical dislocation. Peri-implant tissue was fixed in HEPES buffer containing 2.5%
glutaraldehyde and 5% formaldehyde. The samples were washed with HEPES buffer and then incubated for one hour at room temperature in 1% aqueous osmium solution.
Samples were dehydrated by serial incubation in acetone-water mixtures with increasing acetone concentrations (10%, 30% and 50%) on ice, followed by a dehydration step in 70% acetone. Then the samples were incubated overnight in 70% acetone and 2% uranyl acetate at 4°C. The following day, the dehydration process was continued in 90% and 100% acetone on ice and eventually in 100% acetone at room temperature. Samples were then embedded in epoxy resin as previously described [44] .
Ultrathin sections from these samples were prepared with a diamond knife, picked up with butvar-coated grids, counterstained with uranyl acetate and lead citrate and 
Histological procedures
For histological analysis, animals were sacrificed by CO2 asphyxiation followed by cervical dislocation. Infected peri-implant tissues were isolated and fixed in 4%
formalin for three days as previously described in detail [45] . Briefly, samples were dehydrated in a series of increasingly concentrated ethanol solutions and then A c c e p t e d M a n u s c r i p t 9 embedded in paraffin. Histological slides of approximately 3µm thickness were prepared from paraffin embedded tissue samples. The sections were stained with Hematoxylin and Eosin (H&E) or Periodic Acid Schiff (PAS) staining according to standard laboratory procedures. Moreover, immunohistology staining for Pseudomonas was performed with rabbit-polyclonal anti-Pseudomonas, (Biotrend, AP086) after heatmediated antigen retrieval. The samples were evaluated histo-pathologically on microscope slides using a light-microscope, randomized and blinded to the experimental groups.
Tissue homogenization and colony forming unit assay
One week after infection, mice bearing biofilms were peacefully euthanized with CO2 followed by cervical dislocation and their visceral cavities were opened. Visceral organs such as liver, spleen and gut were removed and their weights were measured. In parallel, subcutaneously implanted magnesium discs inundated with biofilms and the adjacent tissue mass were isolated. Liver, gut and peri-implant tissue were then shifted in homogenization tubes containing 0.1% (v/v) X-100/PBS Triton solution. These tubes were then fixed in Polytron PT3000 homogenizer (Kinematica) and homogenization process was carried for 86 seconds. Explanted infected magnesium discs were directly submerged in PBS and vigorous vortexed for 5 min. at max. speed to disrupt attached biofilm mass. Samples were analyzed for bacterial cell density (CFU/ml) by tenfold serial dilution and plating on LB plates kept at 37°C for 18h. A c c e p t e d M a n u s c r i p t
Results
P. aeruginosa biofilm formation on magnesium implants in a mouse model
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A major challenge towards establishing a biofilm mouse model is rapid elimination of bacteria by host immune system. To establish a mouse model which supports biofilm infections for prolonged period of time, we implanted subcutaneously three magnesium discs at selected locations in a mouse and then injected bioluminescent P. aeruginosa (PAO1) directly on each of these implants (Figure1, d0). In agreement with our previous findings, magnesium implants augmented the survival of bacteria on their surfaces [32] . Bacteria formed biofilms on magnesium and persisted for two weeks on the surface of these implants (Figure1, d0-d14). This experiment confirmed and reproduced our previous findings in that magnesium promotes biofilm formation for extended period of time. While, there is not a single mouse model which allows biofilm formation on metallic implants with plain surfaces in the presence of active host immune system. Therefore, we employed this system to investigate distribution of biofilm infections and associated host immune responses. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 11
Injected bacteria provoke a local interferon type I immune response that can be visualized in transgenic mice by in vivo imaging
Type-I interferon response is triggered by various host cells and plays critical role during the course of viral or bacterial infections. To investigate interferon response against magnesium-based prolonged P. aeruginosa infections, we employed IFN-β reporter mice. In these transgenic mice, luciferase is expressed together with IFN-β which is a virally and bacterially induced cytokine [41] . Magnesium implants were placed subcutaneously in IFN-β reporter mice. Implanted magnesium discs were then infected with wild type P. aeruginosa (PAO1) and the IFN production was observed by in vivo imaging. Side by side, IFN response measured from subcutaneously implanted sterile magnesium and P. aeruginosa injected into subcutaneous sham surgical pouches without implants served as controls. Immediately after infection, IFN response was not in detectable limits of the system from the subcutaneous regions in mice carrying infected magnesium, sterile magnesium or infected tissue (Figure 2Ad0 , a-c). After one day, robust IFN-β-luciferase activities were detected from the sites that were infected either with P. aeruginosa alone or in the presence of magnesium implants ( Figure 2A,   d1(a-c) ). IFN-based luminescence was not observed from the sites with sterile magnesium implants during the entire course of experiment (Figure 2A, d1b) . In vivo expression of IFN-β induced by bacteria administered into sham surgical pouches was detectable for two days and then disappeared. However, robust and prolonged IFN response detectable for two weeks was measured from magnesium infected with P. aeruginosa ( Figure 2B, filled circles) . Moreover, tissue necrosis was observed from these regions (pictures not shown). These results confirm our previous findings that magnesium implants support biofilm formation by P. aeruginosa even in reporter mice. A c c e p t e d M a n u s c r i p t
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Prolonged IFN production and resulting tissue necrosis confirm that P. aeruginosa biofilms provoke severe localized immune reactions. 
P. aeruginosa biofilms cause intense accumulation of host immune cells
A prolonged IFN response against P. aeruginosa biofilms provided evidence that these infections remain restricted at the site of infection. To confirm and to explore the distribution of biofilms, implants after one week of infection were isolated together with adjacent tissue and subjected to electron microscopic analyses. SEM analysis Figure 3D ; white arrows). P. aeruginosa were observed both intra-and extracellularly in PMN at the site of biofilm formation ( Figure 3F ; asterisk symbols). This proves that process of biofilm formation was taking place in the presence of active immune cells which were indeed capable of engulfing bacteria around biofilms. Overall, it appeared that bacteria could utilize implant-tissue interfaces to establish biofilms and their distribution was limited to a short distance in the tissue where the spread of the infection was restricted by host immune cells. A c c e p t e d M a n u s c r i p t 
P. aeruginosa biofilms induce strong inflammatory responses in adjacent tissue
Host inflammatory response against bacterial invasion and foreign material is expected phenomenon [46, 47] . Contrary to planktonic cultures, biofilms bacteria persist longer in within host tissue even in the presence of active immune system. To evaluate intensity of inflammatory reaction induced by P. aeruginosa biofilms, tissue sections were isolated from mice bearing luminescent P. aeruginosa biofilms on magnesium implants after one week of infection and then subjected to hematoxylin and eosin staining. For comparison, tissue sections form sham surgical pouches infected with P. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 15 aeruginsoa and implanted with sterile magnesium were taken as controls. After a week, luminescent P. aeruginosa had established biofilms on magnesium implants. Bacteria injected in a sham surgical pouch in the absence of implants disappeared within few days. In an overview, the part of tissue that housed P. aeruginosa biofilms exhibited high degree of inflammation with more obvious infiltration of severe neutrophilic inflammatory infiltrates surrounding the bacterially infected implants ( Figure 3A 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
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Evidence of biofilm constituents in peri-implant tissue
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Biofilm matrix is mainly composed from sugar polymers and proteins that can be visualized by periodic acid-Schiff (PAS) staining [48, 49] . Even though, electron microscopic analyses clearly revealed P. aeruginosa biofilms in tissue however PAS staining was applied to further verify P. aeruginosa biofilms in the tissue near infected magnesium implants. As expected, PAS positive material indicative for the presence of biofilms matrix was detected in tissue harboring infected magnesium implants ( Figure   4A and B, black arrow). While, no PAS positive material could be detected near infected areas in the absence of implants or in tissue with sterile magnesium implants ( Figure 4C to F). The data also indicated that bacterial implant infections were not solely restricted to implant surface. Instead, they expanded a short distance into the tissue and were walled off by host immune cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t Previous analyses confirm that tissues near infected implants are filled with P. aeruginosa biofilms. To identify bacteria in tissue, antibodies targeting P. aeruginosa were applied on the tissue sections isolated from the vicinity of infected magnesium.
Interestingly, a distinct region positive for pseudomonas staining was visible in the tissue ( Figure 5A, grey area marked by a black arrow) . At high magnification, it could be seen that P. aeruginosa were dispersed within this particular area of biofilm formation ( Figure 5B , black arrow pointing P. aeruginosa). The area positive for pseudomonas staining was surrounded by high influx of inflammatory cells which confirms biofilm resistance towards host immune cells ( Figure 5B , black arrow). Tissue bearing sterile magnesium or infected with bacteria alone were negative for pseudomonas staining ( Figure 5C to F) . Overall, various tissue staining techniques confirmed that P. aeruginosa biofilms were not limited to the implant surface instead they penetrate into the nearby tissue and trigger the induction of strong immune reactions (Table 1) .
Table 1
Inflammation intensity in tissue adjacent to biofilm bearing magnesium discs, magnesium alone and infection alone. Numbers indicate an arbitrary inflammatory score from 0 (no response observed in any of three samples) to 4 (distinct inflammatory response in all three samples investigated). The data shown were compiled by an extensive analysis by an experienced histologist. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t Figure 6 : P. aeruginosa infections originating from medical implant surfaces extend into the adjacent tissue. As described in the legend of Figure 1 , peri-implant tissue was fixed and subjected to P. aeruginosa-specific immuno staining. P. aeruginosa biofilms in peri-implant tissue (A and B black arrows), immuno-stained tissue infected with bacteria in the absence of implants (C and D) and tissue bearing sterile magnesium implants (E and F). Labeled structures are same as described in the legend of Figure 3 . Black arrows indicate regions with evidence for biofilm formation.
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Splenomegaly in mice with P. aeruginosa infected magnesium implants
Strong immunogenic and tissue inflammatory reactions associated with the presence of magnesium based P. aeruginosa biofilms convince that these infections are not localized and can spread into adjacent tissue. In the next step, systemic effects of biofilms were investigated by observing liver, spleen and gut of mice bearing P. aeruginosa biofilms.
These organs were then homogenized and number of bacteria was determined.
Bacterial colony forming units could not be counted from liver or spleen except intestine which seemed normal flora ( Table 2) . Morphology of intestine and liver of mice bearing P. aeruginosa biofilms was normal and similar to un-infected animals.
Surprisingly, size as well as weight of spleen isolated from infected mice had increased 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 19 compared to un-infected mice ( Figure 7A compare a with b) . These results provide evidence that biomaterial-associated biofilm infections in host affect systemic organs, particularly spleen. Importantly, such significant increase in the size and weight of spleen are indicative of additional complications for patients suffering from biomaterial-associated infections. 
Discussion
The results in this study confirm and refine previous results in that in vitro antibacterial properties of pure magnesium are not sufficient to prevent bacterial colonization of A c c e p t e d M a n u s c r i p t 20 implants and instead apparently even promote prolonged bacterial survival under in vivo situations. We and some other studies have previously reported that in vitro antibacterial properties of magnesium are due to high alkalization therefore one explanation for the absence of in vivo antimicrobial properties could therefore be the absence of high pH in the peri-implant tissue controlled by the efficient body buffering system [26, 50] . In addition, development of conditioning film by blood plasma or wound liquid creates a barrier for the dissemination of magnesium corrosion products thereby allowing colonization of bacteria [51, 52] . Since, hydrogen gas is degradation product of magnesium corrosion, it cannot be excluded that the formation of gas pockets on magnesium surface provides protection to bacteria from early host cells invasion and subsequently develop biofilms. Therefore, before clinical applications can be envisioned, it will be necessary to enhance antibacterial properties of magnesium.
Since magnesium alloys can be manufactured that have superior mechanical qualities, it could be envisioned to add antibacterial acting metal alloys, such as copper or silver [53, 54] . Since in this study no spontaneous infections of magnesium alloy implants were observed, it may be sufficient to provide a temporary protection for a limited time after surgery by antibiotic-releasing coatings until the wound has closed and the implant is protected by a fibrous capsule [55] . By the application of these strategies susceptibility of magnesium implants towards biofilm infections could be reduced and it can be promoted for clinical applications.
Pseudomonas aeruginosa is significant pathogen responsible for implant failure in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 21 these biofilms. To answer these questions, the major challenge is lack of clinically relevant animal models. Previous studies report that bacterial biofilms are mainly restricted on or near the surfaces of implant materials because mechanical and structural properties of these materials which protect them from being engulfed by the host immune cells [56] [57] [58] . Whereas, a recent study reported that S. epidermidis biofilms penetrated into the nearby tissues after initially growing on implanted materials resulting in robust inflammatory immune reactions [35] . However, in depth characterization of biofilms-mediated immune responses were not done in any of these studies. Here, we report for the first time biofilm mediated immune responses in a highly sensitive reporter mouse expressing type I interferon luciferase under transcriptional control of the IFN-ß promoter [41] . Our results indicate robust and persistent type-I IFN induction from P. aeruginosa biofilms s as compared to controls.
IFN responses against P. aeruginosa biofilms were not immediate and were visible after 24 hours of infection. Though molecular mechanisms for delayed IFN response were not investigated however an explanation could be that initially injected planktonic bacteria were not sufficient to stimulate IFN production. While at later stages, bacterial number increased by biofilm formation resulting in IFN production. It also confirms that P. aeruginosa biofilms are recalcitrant against immune system even in the presence of IFN secreting active host cells. Additionally, we restricted our research to the finding that strong IFN production is induced in response to P. aeruginosa biofilms. However, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 systemic organ infiltration by bacteria could be detected by using the approaches described in this study however splenomegaly in mice with biofilms was observed.
Splenomegaly is reported due to various reasons but it is the first time that we observed it in animal suffering from biofilm infections [62, 63] . It is possible that cytokines or migratory immune cells originating at the infected region could affect the inflammatory spleen response. Increases in the spleen size could nevertheless be indicative of systemic bacterial spread, perhaps at a level too low to detect by the methods applied here or it could be caused by the systemic distribution of inflammatory bacterial degradation products.
The present study validated both localized and systemic inflammatory immune responses to bacterial biofilms established on magnesium implant surfaces. Thus, novel strategies need to be established to control such infections.
Conclusion
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